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Abstract. – OBJECTIVE: The aim of this in 
vivo study was to evaluate two different types 
of implant-abutment connections: screwed con-
nection and cemented connection, analyzing 
peri-implant bacteria microflora as well as other 
clinical parameters.
PATIENTS AND METHODS: Twenty implants 
were selected, inserted in 20 patients, 10 with a 
screwed implant-abutment connection (Group 1) 
and 10 with a cemented implant-abutment con-
nection (Group 2). The peri-implant microflora 
was collected, after at least 360 days from the 
prosthetic rehabilitation, using paper points in-
serted in peri-implant sulcus for 30 s. Polymera-
se chain reaction (PCR) Real-time analyzed the 
presence of 9 bacteria periodontal-pathogens 
and Candida albicans.
RESULTS: Our findings showed that bacte-
ria colonized all Groups analyzed, the average 
bacterial count was 3.7 E +08 (±1.19) in Group 
1, compared to 2.1 E +08 (±0.16) in Group 2; 
no statistically significant differences were 
observed (p > 0.0.5). In Group 1, however, bac-
terial colonization of peri-implant sulci was 
over the pathogenic threshold for 5 bacteria, 
indicating a high-risk of peri-implantitis. Al-
so in Group 2, results showed a microflora 
composed by all bacteria analyzed but, in this 
case, bacterial colonization of peri-implant 
sulci was over the pathogenic threshold for 
only 1 bacterium, indicating a lower risk of 
peri-implantitis. Moreover, clinical parameters 
(PPD > 3 mm and m SBI > 0) confirmed a great-
er risk of peri-implantitis in Group 1 compared 
to Group 2 (p < 0.05). 
CONCLUSIONS: We concluded that, also af-
ter only 360 days, implants with screwed con-
nection showed a higher risk of peri-implantitis 
that implants with cemented connection.
Key Words
Implant-abutment connection, Screwed connec-
tion, Cemented connection, Microbiological leakage, 
Peri-implantitis.
Introduction
Nowadays, dental implant surgery is a widely 
used procedure to replace missing teeth; over the 
years improvements in design, surface and sur-
gical protocols have made implants a secure and 
highly predictable procedure with a mean surviv-
al rate of 94.6% and mean success rate of 89.7% 
after more than 10 years1. Dental implant failures 
are essentially mechanical or biological, and they 
are classified on a chronological basis as: a) ear-
ly complications, resulting from surgical trauma, 
inadequate bone volume, lack of primary stabil-
ity, bone infection or bacterial contamination; 
b) late complications, related to microbiologi-
cal (peri-implantitis) and biomechanical chang-
es (occlusal overload)2. Dental implant systems 
consist of two main parts: the abutment and the 
implant body. The implant-abutment connection 
represents the weakest point of the dental implant, 
due to a micro-gap between the implant-abutment 
interface, which may cause microbial leakage. 
These hollow spaces may act as reservoir for com-
mensal and/or pathogenic bacteria, especially an-
aerobic or micro-aerophilic species, representing 
a potential source of tissue inflammation, which 
may lead to bone resorption3-6. Several Research-
es7,8 have shown that either micro-movements or 
bacterial leakage may be considered as triggers 
factors for peri-implantitis. Sixth European Work-
shop in Periodontics of 2008 defined peri-im-
plant diseases as: a) mucositis is the presence of 
inflammation of the peri-implant mucosa without 
signs of loss of bone support; b) peri-implantitis is 
characterized by a loss of bone support, in addic-
tion to inflammation of the mucosa9. Microbiota 
associated to peri-implantitis are very similar to 
periodontal diseases, such as the species of the 
red and orange complexes, Prevotella nigrescens, 
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Campylobacter rectus and Aggregatibacter acti-
nomycetemcomitans, as well as Staphylococcus 
aureus, Enteric bacilli and Candida albicans10,11. 
Increases in pocket depth and bone loss are asso-
ciated with significant changes in the composition 
of sub-gingival microbiota, including: an increase 
of total bacteria load, with higher values of Aggre-
gatibacter actinomycetemcomitans, Fusobacteri-
um species, Prevotella intermedia and Porphyro-
monas gingivalis12. The aim of this study was to 
evaluate peri-implant bacteria microflora in two 
different types of implant-abutment connection 
systems, after at least 360 days of prosthetic load-
ing. The authors hypothesized that screwed-re-
tained connections may show higher values of 
total bacterial count.
Patients and Methods 
Study Design
To address the research purpose, the authors 
designed and implemented a randomized clinical 
trial, conducted at the Department of Oral and 
Maxillo-Facial Sciences, at “Sapienza” Universi-
ty of Rome. The study was approved by the local 
Ethic Committee (Ref. 3691). The study sample 
was composed of a population of subjects present-
ing at the University’s Department for Implant 
Treatment of the Premolar/Molar Region. To be 
included in the study sample, patients had to meet 
specific inclusion and exclusion criteria (Table I).
Study Variables
The binary predictor variable was im-
plant-abutment connection and included screwed 
retained implant-abutment connection or cement-
ed implant-abutment connection. The prima-
ry outcome variable was Total Bacterial Count 
(TBC), measured by quantitative Real-time PCR. 
Secondary variables included specific bacterial 
counts for 10 microbiota: Aggregatibacter acti-
nomycetemcomitans (Aa), Porphyromonas gin-
givalis (Pg), Tennerella forsythensis (Tf), Trepo-
nema denticola (Td), Prevotella intermedia (Pi), 
Peptostreptococcus micros (Pm), Fusobacterium 
nucleatum (Fn), Campylobacter rectus (Cr) and 
Eikella corrodens (Ec); Candida Albicans (Ca). 
Other variables recorded included clinical and 
radiological peri-implant parameters:
  • PPD (Probing Pocket Depth);
  • m SBI (Modified Sulcus Bleeding Index) 
(Mombelli et al 1987)13;
  • m GI (Modified Gingival Index) (Mombelli et 
al 1987)13;
  • m PI (Modified Plaque Index) (Mombelli et al 
1987)13;
  • REC (Gingival Recession);
  • Peri-implant bone loss.
Surgical and Prosthetic phases
Patients were divided into two groups based on 
implant-abutment connection type: implant with 
screwed implant-abutment connection (Group 
1) and implant with cemented implant-abutment 
connection (Group 2). Randomization for im-
plant-abutment connection type was performed 
by simple allocation: a total of 10 patients were 
treated for each group. Two different implant 
systems were used: in Group 1 were placed im-
plants with a machined surface made of commer-
cially pure titanium grade 4; in Group 2 implants 
with surfaces sanded with aluminum oxide me-
dium grade particles (250 µm) and etched with 
a solution of hydrofluoric acid at 3% and nitric 
acid at 30%, with a fixture›s core made of com-
mercially pure titanium grade 4. Two experienced 
surgeons (FM, PP) performed all surgical proce-
dures, following the same surgical protocol (Ta-
ble II). Prosthetic rehabilitation was performed in 
an interval of time between 3 or 4 months after 
surgical treatment. Total thickness flaps were per-
formed to discover implants and healing collars 
were placed for 14 days, before impression tak-
ing. Subsequently, implants were rehabilitated 
using metal-ceramic crowns: only single crowns 
were performed. For Group 1, the abutment was 
Table I. Inclusion and exclusion criteria.
Inclusion criteria
• Age >18 years
• Agreed to be included in the study and signed 
 informed consent form
• Need of implant treatment in premolar/molar region
• FMPS < 25% and FMBS < 25%
• Absence of bleeding on gentle probing (<0.25N), PPD 
 <5 mm and absence of radiographic bone loss 
 assessed in paralleled periapical radiographs 
 (Lang & Berglundh 2011)
Exclusion criteria
• Uncontrolled systemic diseases 
• Use of drugs (antibiotics, anti-inflammatory
 and corticosteroids) in the previous 3 months
• Untreated acute oral diseases (caries, endodontic  
 lesions, periodontal disease)
• Surgical treatment for peri-implantitis or periodontal  
 disease in the previous 6 months
• Bruxism or clenching parafunctional habits
• Smokers (>10 cigarettes/day)
• Pregnant or lactating patients
• History of mental disorders
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inserted into the implant and jointed with connec-
tion screw using the specific screwdriver and then 
the dynamometric ratchet, tightening the screw 
to 25 Ncm as per manufacturer specification. For 
Group 2, the collar was inserted inside the fixture 
using a specific device. The abutment, then, was 
cemented with Panavia 2.1 (J. Morita, Irvine, CA, 
USA). The cement was mixed according to man-
ufacturer’s recommendations and applied on the 
axial surface of the internal portion of the implant 
to minimize hydrostatic pressure during sealing. 
Abutments were cemented on the implants with 
load of 5 kg maintained for 10 min. The cement in 
excess was removed with a scaler. Two expert in-
vestigators performed all procedures (FDS, DR). 
After screwing or cementing implant-abutment 
connection, crowns were cemented on the implant 
with a non-eugenol zinc oxide provisional cement 
(TempBond NE, Kerr Dental, Orange, CA, USA). 
The cement in excess was removed with an ul-
trasonic scaler. Patients were then included in a 
professional hygiene maintenance protocol every 
three months.
Data collection
One implant for each patient was randomly se-
lected to perform the microbiological assessment, 
clinical and radiological peri-implant measure-
ments, as well as to analyze cumulative implant 
survival rate using the Kaplan-Meier survival 
analysis. After 12 months of prosthetic loading, 
bacteria collection was performed. Samples were 
obtained from the peri-implant sulcus in 6 sites 
around each implant: Buccal, Mesio-Buccal, Dis-
to-Buccal, Palatal, Mesio-Palatal, Disto-Palatal. 
Sampling was performed using sterile absorbent 
paper tips inserted into the peri-implant sulcus 
for 30 s. Prior to subgingival plaque sampling, 
supragingival plaque was removed from implants 
and neighboring teeth using Teflon curettes Im-
placare (Hu-Friedy Mfg. Co., LLC, Chicago, IL, 
USA) without penetrating the gingival or peri-im-
plant sulcus. Cotton rolls were used for relative 
isolation and sampling sites were dried with air. 
The paper tips, with the samples, were placed 
into the Eppendorf tubes (Eppendorf AG, Ham-
burg, Germany) and were sent for microbiolog-
ical analysis to the laboratory Institut Clinident 
SAS (Aix-en-Provence, France) in the provided 
mailing envelopes. After the sampling, a clinical 
exam was performed in 6 sites around implant us-
ing a millimetric probe HAWE CLICK-PROBE 
(Hawe Neos Dental, Bioggio, Switzerland) and 
PPD was recorded. As for m SBI, m GI and m PI, 
they were evaluated in 4 sites around implant and 
the mean value was calculated getting implant’s 
score. Presence or absence of REC was evaluat-
ed. A standardized periapical radiograph (Rinn, 
Dentsply, York, PA, USA) was taken for each im-
plant to evaluate peri-implant bone loss levels.
Quantitative Real-time PCR assays
Quantitative real-time PCR was carried out 
for Total Bacterial Count (TBC) and for 10 patho-
gens: Aggregatibacter actinomycetemcomitans 
(Aa), Porphyromonas gingivalis (Pg), Tennerel-
la forsythensis (Tf), Treponema denticola (Td), 
Prevotella intermedia (Pi), Peptostreptococcus 
micros (Pm), Fusobacterium nucleatum (Fn), 
Campylobacter rectus (Cr) and Eikella corrodens 
(Ec); and more Candida Albicans (Ca). Quanti-
tative Real-time PCR assays were performed in 
a volume of 10 1l composed of 1 9 QuantiFast® 
SYBR® Green PCR (Qiagen, Hilden, Germany), 
2 1l of DNA extract and 1 1M of each primer. The 
species-specific PCR primers used in this study 
were provided by Institut Clinident SAS (Aix-
en-Provence, France) and manufactured by Me-
tabion GmbH (Metabion International AG, Plan-
neg, München, Germany). The bacterial primers 
used were derived from previously published ri-
bosomal 16 S sequences14,15 and were adapted to 
Real-time PCR conditions. Assays were carried 
out on the RotorGene® Q thermal cycling system 
(Qiagen, Hilden, Germany) with the following 
program: 95°C for 5 min, followed by 40 cycles 
of 10 s at 95°C, 10 s at 60°C, and 35 s at 72°C. A 
final melt curve analysis (70 to 95°C in 1°C steps 
for 5s increments) was done. Fluorescence sig-
nals were measured every cycle at the end of the 
Table II. Surgical protocol.




• Supra-gingival debridement and oral hygiene 
 instructions
• Local anesthesia with adrenaline 1:100.00
• Rinse with chlorexidine 0.2% for 60 s 
• Total thickness flap, preserving periodontium of 
 adjacent teeth
• Detachment of muco-periosteal flap
• Preparation of implant site with progressive diameter 
 drill, following manufacturer’s recommendations
• Control with paralleled periapical radiographs
• Implant placement with submerged technique
• Silk sutures 3-0
• Post-surgical instruction (antibiotic, anti-
 inflammatory, corticosteroids)
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extension step and continuously during the melt 
curve analysis. The resulting data were analyzed 
using Rotor-Gene® Q Series software (Qiagen, 
Hilden, Germany). Serial dilutions of bacterial 
standard DNA provided by Institut Clinident SAS 
were used in each reaction as external standards 
for absolute quantitation of the targeted bacteri-
al pathogens. Standard bacterial strains used for 
standard DNA production were obtained from 
DSMZ (Braunschweig, Germany), CIP Collec-
tion of Institut Pasteur (Paris, France) or from 
BCMM/LMG Bacteria Collection (Ghent, Bel-
gium): Aa (DSM No. 8324), Pg (DSM No. 20709), 
Tf (CIP No. 105220), Td (DSM No. 14222), Pi 
(DSM No. 20706), Pm (DSM No. 20468), Fn 
(DSM No.20482), Cr (LMG No. 18530), Ec (DSM 
No. 8340).
Statistical Analysis
At the end of study all collection data were in-
serted in a work sheet (Microsoft Excel, Microsoft 
Corporation, Redmond, WA, USA) in a personal 
computer (Macbook Pro, Apple, Cupertino, CA, 
USA) and analyzed using a specific software (IBM 
SPSS V10 Statistics, IBM, Armonk, USA). Dif-
ferences in the bacterial counts from two groups 
were compared using the Mann-Whitney U test. A 
p-value <0.05 was considered significant.
Results
A total of 20 patients were selected, 10 male 
and 10 female, with a mean age of 46.67 years 
(range= 27-62 years). A total of 50 implants 
were placed, 25 for each group (Table III). The 
follow-up ranged between 360 days and 2 years 
with a mean follow-up of 484 days, approximate-
ly 1 years and 4 months (Table IV). Three upper 
right first molars, six upper left first molars, two 
lower left first molars and nine lower right first 
molars were included in this study. All peri-im-
plant sulci showed a bacterial colonization, but 
in Group 1 presence of bacteria showed higher 
values compared to Group 2. The average total 
bacterial count was 3.7 E+08 (±1.19) for Group 1, 
compared to 2.1 E+08 (±0.16) in Group 2, with-
out statistically significant differences (p=0.32). 
Group 1 showed a microflora composed by all 
bacteria analyzed, excluding Aggregatibacter 
actinomvcetemcomitans and Candida albicans. 
Table III. Patient’s demographics and treatment sites.
N° Name Gender Age Edentulous
      Area 
  1 BD F 44 3.6-4.7
  2 PR M 53 1.5-1.6-3.6-4.6
  3 PL F 47 1.6-2.6-4.4
  4 RB F 29 4.5-4.6
  5 BM M 50 1.4-4.6
  6 SA M 39 2.4-2.6
  7 DV F 57 2.5-2.6-4.6
  8 DG F 33 1.5-1.6
  9 MV M 48 1.4-4.6
10 PS F 37 2.4-2.5-2.6
11 BA M 61 1.5-1.6-2.4
12 CM F 38 4.6
13 ZA M 44 2.4-2.5-2.6-2.7
14 ST F 47 3.6-4.6
15 LM F 49 3.5-4.6
16 MS M 56 2.5-2.6
17 PA F 46 1.5-3.6
18 AN M 27 2.5-4.5-4.6
19 JGD M 45 2.5-4.6-4.7
20 RG M 62 1.4-1.5-1.6
N°          Group 1         Group 2
         (screwed implant-        (cemented implant 
      abutment connection)     abutment-connection)
 Name Follow-up Implant Site Name Follow-up Implant Site
 
  1 BD 710 days 3.6-4.7 BA 537 days 1.5-1.6-2.4
  2 PR 382 days 1.5-1.6-3.6-4.6 CM 504 days 4.6
  3 PL 410 days 1.6-2.6-3.6 ZA 479 days 2.4-2.5-2.6-2.7
  4 RB 378 days 4.5-4.6 ST 516 days 3.6-4.6
  5 BM 546 days 1.4-4.6 LM 488 days 3.5-4.6
  6 SA 625 days 2.4-2.6 MS 689 days 2.5-2.6
  7 DV 630 days 2.5-2.6-4.6 PA 716 days 1.5-3.6
  8 DG 426 days 1.5-1.6 AN 372 days 2.5-4.5-4.6
  9 MV 398 days 1.4-4.6 JGD 412 days 2.5-4.6-4.7
10 PS 362 days 2.4-2.5-2.6 RG 381 days 1.4-1.5-1.6
Table IV. Study design and follow-up. The red sites are implants included in the study sample.  
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The bacterial colonization of peri-implant sulci 
was over the pathogenic threshold for 5 bacteria 
(Porphyromonas gingivalis, Tannerella forsyth-
ia, Treponema denticola, Prevotella intermedia, 
Campylobacter rectus) indicating a high-risk of 
peri-implantitis (Figure 1). Also Group 2 showed 
a microflora composed by all bacteria analyzed, 
excluding Aggregatibacter actinomycetemcom-
itans. In this case, the bacterial colonization of 
peri-implant sulci was over the pathogenic thresh-
old for only 1 bacterium (Prevotella intermedia), 
indicating a low-risk of peri-implantitis. A patient 
presented Candida albicans disease (Figure 2, 
Figure 3). Clinical examinations showed different 
Figure 1. Group 1, screwed implant-abutment connection, average results. *Pathogenic load: the amount of detected bacteria in sam-
ple; **Pathogenic threshold: Represents a specific microbiological pathogenic load above which antibiotic therapy is recommended in 
order to reduce risk of tooth or implant attachment loss (periodontal disease or peri-implantitis). ***Status: levels of microbiological 
pathogenic load: - Absent; + Moderate and less than the pathogenic load threshold; ++ High and more the pathogenic load threshold. As-
sociated with aggressive forms of disease; +++Very high and more than 10 times above the pathogenic load threshold; ++++ Very strong 
association with aggressive forms of disease and loss of bone attachment ; Negative, absence of Candida albicans/ Positive, presence of 
Candida albicans. ****%Total Bacterial Count: relative proportion of a specific bacterial versus total bacterial count; N/A not available.
Figure 2. Group 2, cemented implant-abutment connection, average results. *Pathogenic load: the amount of detected bacteria in sam-
ple; **Pathogenic threshold: Represents a specific microbiological pathogenic load above which antibiotic therapy is recommended in or-
der to reduce risk of tooth or implant attachment loss (periodontal disease or peri-implantitis). ***Status: levels of microbiological patho-
genic load: - Absent; + Moderate and less than the pathogenic load threshold; ++ High and more the pathogenic load threshold. Associat-
ed with aggressive forms of disease; +++Very high and more than 10 times above the pathogenic load threshold; ++++ Very strong asso-
ciation with aggressive forms of disease and loss of bone attachment; Negative, absence of Candida albicans/ Positive, presence of Can-
dida albicans. **** % Total Bacterial Count: relative proportion of a specific bacterial versus total bacterial count; N/A not available.
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results for implants with screwed implant-abut-
ment connection and implants with cemented 
implant-abutment connection (Tables V, VI). In 
Group 1, fourteen sites showed PPD values of 
more than 3 mm (23%), with an average probing 
of 3.1 mm. In Group 2, only 2 sites reported values 
higher than 3 mm (3%) with an average probing 
of 1.8 mm (p=0.0013; p<0.05, X2 test). Bleeding at 
probing was presented in 8 implants in Group 1 
(80%) and in 6 in Group 2 (60%) (p=0.04; p<0.05, 
X2 test). Gingival alterations were evaluated in 6 
cases (60%) in Group 1 and in only 2 cases (20%) 
in Group 2. Mechanical failures were report-
ed in two cases (20%) in Group 1, identified as 
abutment loosening, and in one case for Group 
2, identified as abutment decementation. Radio-
graphic alterations were noticed in two implants 
for Group 1 and in one implant for Group 2, but 
without signs of severe pathogenicity. 
Discussion
In this study, a higher risk of developing 
peri-implantitis was found in Group 1, associated 
with a major presence of pathogenic bacteria of 
the “red” complex over the pathogenic threshold 
(Figures 4 and 5). Moreover, clinical examination 
data confirmed the hypothesis about a correlation 
between connection type and presence of peri-
odontal pathogenic bacteria. Nowadays, frequen-
cies of peri-implant diseases, such as mucositis 
and peri-implantitis, are respectively 54-80% and 
28-56% for patients and 32-50% and 12-43% for 
Figure 3. Group 1bacterial leakage, aver-
age results. Aa: Aggregatibacter actinomy-
cetencomitans; Pg: Porphyromonas gingi-
valis; Tf: Tannerella forsythia; Td: Trepo-
nema denticola; Pi: Prevotella intermedia; 
Pm: Parvimonas micra; Fn: Fusobacteri-
um nucleatum; Cr: Campylobacter rectus; 
Ec: Eikenella corrodens; Ca: Candida al-
bicans.
Table V. Results of clinical examinations in Group 1.
PPD: probing pocket depth, the red numbers are the probing > 3 mm; m SBI: modified Sulcus Bleeding Index, 0- absent of bleeding, 
1- bleeding to isolate spot, 2- linear bleeding, 3- spontaneus and profuse bleeding; m GI: modified Gingival Index, 0- normal 
mucosa, 1- edema, 2- edematous and polishes mucosa, 3- marked redness, edema, spontaneous bleeding; m PI: modified Plaque 
Index, 0- absence of plaque, 1- plaque detectable with probe, 2- visible plaque, 3- presence of abundant plaque deposits; REC: 
gingival recession, + present, - absent; Mf: mechanical failure, + present, - absent; Rx: radiographic alterations, + present, - absent.
N° Name Site             PPD    mSBI mGI mPI REC Mf Rx
   B MB DB P MP DP
  1 BD 3.6 3 3 3 2 4 3 1 2 0 + + +
  2 PR 4.6 5 3 6 2 2 3 2 2 1 + - -
  3 PL 2.6 3 3 4 3 3 4 1 1 1 + + -
  4 RB 4.6 2 2 3 2 3 2 0 0 1 - - -
  5 BM 4.6 3 3 2 3 4 2 1 0 0 - - -
  6 SA 2.6 2 2 4 3 2 2 1 0 2 - - -
  7 DV 2.6 4 5 6 3 3 3 2 2 2 + + +
  8 DG 1.6 3 4 3 3 4 3 1 0 1 - - -
  9 MV 4.6 3 2 3 3 2 3 0 1 1 - - -
 10 PS 2.6 3 4 5 3 3 3 1 1 0 - - -
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implants16,17. The presence of a pathogenic micro-
flora in a initial phase can be associated with an 
higher risk of peri-implantitis, as per periodontal 
diseases18,19. In 1992, Socransky and Haffajec20 
modified the postulates of Koch establishing 
criteria that identify periodontal pathogens. The 
study of biofilm using DNA hybridization tech-
niques made possible to individuate specific bac-
terial species and relate them to clinical health or 
disease. While the “purple” (with fundamental-
ly aerobic flora lacking mobility), “yellow” and 
“green” complexes are not associated to disease, 
the “orange” (F. nucleatum, P. intermedia, P. mi-
cros) and “red” complexes (P. gingivalis, T. for-
sythia, T. denticola) are disease-related. A. acti-
nomycetemcomitans is also considered as being 
periodontopathogenic, although it is not included 
in any group. Factors influencing disease include 
susceptibility of individual host, presence of inter-
acting bacterial species and local environment of 
periodontal pocket. Several authors21-23 compared 
microbiota founded in dental implants classified 
as being healthy with implants with a diagnosis 
of peri-implantitis (A. actinomycetemcomitans) 
resulted the predominant pathogen implicated in 
peri-implant destruction. Finally, an important 
risk factor for peri-implant disease may be type of 
implant abutment-connection, associated to den-
tal implant position with respect to alveolar bone 
crest24. The presence of a micro-gap between im-
plant and abutment (estimated between 20 and 49 
micron) allows passage of bacteria from peri-im-
plant sulcus to the internal part of implant (in par-
ticular for screwed-implant)25. This environment 
Table VI. Results of clinical examinations in Group 2.
PPD: probing pocket depth, the red numbers are the probing > 3 mm; m SBI: modified Sulcus Bleeding Index, 0- absent of beeding, 
1- bleeding to isolate spot, 2- linear bleeding, 3- spontaneus and profuse bleeding; m GI: modified Gingival Index, 0- normal 
mucosa, 1- edema, 2- edematous and polishes mucosa, 3- marked redness, edema, spontaneous bleeding; m PI: modified Plaque 
Index, 0- absence of plaque, 1- plaque detectable with probe, 2- visible plaque, 3- presence of abundant plaque deposits; REC: 
gingival recession, + present, - absent; Mf: mechanical failure, + present, - absent; Rx: radiographic alterations, + present, - absent.
N° Name Site             PPD    mSBI mGI mPI REC Mf Rx
   B MB DB P MP DP
  1 BA 1.6 3 3 3 4 4 3 2 0 1 - - +
  2 CM 4.6 1 2 2 1 2 2 0 0 0 - + -
  3 ZA 2.6 2 2 2 1 2 2 1 0 1 - - -
  4 ST 4.6 1 1 1 1 1 2 0 0 0 - - -
  5 LM 4.6 1 2 2 1 2 2 1 0 1 - - -
  6 MS 2.6 3 2 3 3 3 3 1 0 2 - - -
  7 PA 3.6 1 2 1 1 1 2 0 0 0 - - -
  8 AN 4.6 1 1 2 1 2 1 1 1 2 - - -
  9 JGD 4.6 2 3 1 2 1 1 0 0 1 - - -
 10 RG 1.6 2 3 3 2 3 3 1 1 2 - - -
Figure 4. Group 2 bacterial leakage, av-
erage results. Aa: Aggregatibacter acti-
nomycetencomitans; Pg: Porphyromonas 
gingivalis; Tf: Tannerella forsythia; Td: 
Treponema denticola; Pi: Prevotella in-
termedia; Pm: Parvimonas micra; Fn: 
Fusobacterium nucleatum; Cr: Campy-
lobacter rectus; Ec: Eikenella corrodens; 
Ca: Candida albicans.
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is more favorable for bacterial growth, especially 
anaerobic bacteria (such as most important paro-
donto-patogenes)26-28. According to the authors, 
further research in the field of microbiological 
peri-implant leakage, with long-term follow-up 
studies, larger sample and different implant-abut-
ment connections, are necessaries to verify the 
hypothesis presented by this study.
Conclusions
According to our findings, even after a maxi-
mum of 2 years of functional loading, peri-implant 
sulcus of both groups presented a colonization by 
“red complex” bacteria and a higher risk to devel-
op peri-implant diseases, confirmed by clinical pa-
rameters. This risk was higher in Group 1 compared 
to Group 2, due to the major presence of bacteria 
associated with peri-implantitis over the pathogenic 
threshold. Within the limitations of this study, it is 
possible to conclude that cemented-tapered connec-
tion is more impermeable that screwed-connection, 
that could be a reservoir of dangerous bacteria.
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